Ashwagandha
- Result Type
- clinical trial
Ashwagandha for Cognitive Dysfunction
Get personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Access award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Get personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Make appointments, message your doctor and more through our patient portal.
Access award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Join our robust training programs led by nationally known healthcare leaders.
Explore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Shape the future of healthcare and build your career within our diverse teams.
You are viewing results from Research and Clinical Trials.
11results found for:
Ashwagandha for Cognitive Dysfunction
Status: Active, Recruiting
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Status: Active, Recruiting
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
Connect® MDS/AML Disease Registry
Status: Active, Recruiting
Randomized, open-label study of TTFields, 150kHz concomitant with gemcitabine and nab-paclitaxel for treatment of locally-advanced pancreatic adenocarcinoma
Status: Active, Recruiting
A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Status: Active, Not Recruiting
AstraZeneca D533AC00001 MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresect
Status: Active, Not Recruiting
A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kd Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal
Status: Completed
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibros
Status: Completed
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.
We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences